Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 3/20 | 1.00 |
| ▸ | CRHR2 | Q13324 | 3/20 | 1.00 |
| ▸ | MYC | P01106 | 3/20 | 0.68 |
| ▸ | MAX | P61244 | 3/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 1/20 | 0.68 |
| ▸ | GSK3B | P49841 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.65 |
| ▸ | NAT1 | P18440 | 5/20 | 0.61 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1249353 | 1.00 | CRHBP (1.00) | CRHBPCRHR2MYCMAXNPC1 | |
| SCHEMBL194499 | 1.00 | CRHBP (1.00) | CRHBPCRHR2MYCMAXNPC1 | |
| SCHEMBL14891689 | 0.95 | CRHBP (0.90) | CRHBPCRHR2MYCMAXNPC1 | |
| SCHEMBL14891688 | 0.95 | CRHBP (0.90) | CRHBPCRHR2MYCMAXNPC1 | |
| SCHEMBL12218499 | 0.89 | CRHBP (0.81) | CRHBPCRHR2MYCMAXNPC1 | |
| SCHEMBL4101541 | 0.88 | CRHBP (0.79) | CRHBPCRHR2NPC1RAB9AGSK3B | |
| SCHEMBL4101538 | 0.88 | CRHBP (0.79) | CRHBPCRHR2NPC1RAB9AGSK3B | |
| SCHEMBL8177383 | 0.85 | CRHBP (0.74) | CRHBPCRHR2MYCMAXNPC1 | |
| SCHEMBL4100036 | 0.84 | CRHBP (0.73) | CRHBPCRHR2NPC1RAB9AGSK3B | |
| SCHEMBL4100041 | 0.84 | CRHBP (0.73) | CRHBPCRHR2NPC1RAB9AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20250149336-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-08 | — | — | US | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| WO-2024043108-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CURED FILM, FILM, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, AND RADICAL POLYMERIZATION INITIATOR | 富士フイルム株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | disclosed |
| US-20020020832-A1 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-21 | — | — | US | disclosed |
| EP-1163553-A1 | OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2001-12-19 | — | — | EP | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| WO-2000052530-A1 | OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-09-08 | — | — | WO | disclosed |
| EP-0733649-B1 | Peroxycarboxylic ester photoinitiators derived from nitrogen heterocycles | MINNESOTA MINING & MFG (US) | 2000-07-12 | — | — | EP | disclosed |
| US-5693442-A | ELEMENT HAVING OVERCOAT OVERLYING CHARGE GENERATING LAYER COMPRISING DYE AND/OR ORGANIC PIGMENT AND COMPLEX OF INORGANIC OXIDE POLYMER AND CHARGE CARRIER | EASTMAN KODAK COMPANY (US) | 1997-12-02 | — | — | US | disclosed |
| US-5599652-A | PHOTOPOLYMERIZABLE MIXTURES ALSO WITH FREE RADICAL POLYMERIZABLE COMPOUNDS AND PHOTOSENSITIZERS | IMATION CORP. (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0733649-A1 | Peroxycarboxylic ester initiators derived from nitrogen heterocycles | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-09-25 | — | — | EP | disclosed |
| US-5527921-A | USEFUL IN PHOTOPOLYMERIZABLE COMPOSITIONS AND PHOTOSENSITIVE ELEMENTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CRHBP 3062/4885CRHR2 3308/4885MYC 2860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.